Company Profile

Endogen Inc
Profile last edited on: 4/5/12      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1983
First Award
1986
Latest Award
1999
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

30 Commerce Way
Woburn, MA 01801
   (781) 937-0890
   N/A
   www.endogen.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In July 1999, Endogen was acquired by PerBio Science AB, a subsidiary of the Swedish Perstorp group. Endogen, Inc. develops, manufactures and sells products for the life science market, specializing in cytokines and chemokines, the chemical messengers of the immune system. Endogen's products are used in a wide variety of biomedical research settings to investigate the underlying immunological mechanisms of diseases including cancer, AIDS, inflammation and autoimmune disorders. Endogen was one of the pioneers in recognizing the importance of the cytokine product niche and today produces the fastest and most accurate kits for measuring cytokines, growth factors, chemokines and other key immune system proteins. Endogen markets a full product line of 54 immunoassay test kits and over 360 specialty reagents. In 1998, Endogen expanded its product offerings with the introduction of proprietary technologies for quantification of messenger RNA ("mRNA"). Messenger RNA molecules convey genetic signals that are stored as DNA in the nucleus to the cell's protein synthesis system. They link genetic signals to the production of certain proteins that render all cellular functions. Endogen's Xplore® assay kits provide rapid and accurate measurement of gene expression through the detection of mRNA levels in aprecise and easy-to-use 96-well assay format.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1999 1 USDA $53,588
Project Title: Cytokine Gene Expression Assays for Swine Health Research
1998 2 USDA $278,995
Project Title: Cytokines and Cytokine assays for swine health assessment and protection
1986 1 NIH $50,000
Project Title: Development of human monocolonal antibodies specific for human interleukin-1

Key People / Management

  Owen A Dempsey -- President

  Roy Dempsey -- President

  Mark D Moody

Company News

There are no news available.